Randomized controlled field trial comparing quarter and cow level selective dry cow treatment using the California Mastitis Test by Swinkels, J.M. et al.
ABSTRACT
Selective use of antibiotic dry cow treatment can be 
implemented at the cow or quarter level, with the latter 
having the potential to further reduce antibiotic use. 
Our objective was to compare these 2 approaches in 6 
herds in the United Kingdom in which environmental 
mastitis predominated. Eight hundred seven cows were 
enrolled and categorized as having a high cell count 
(n = 401) or low cell count (n = 406) in the last 3 mo 
of lactation and clinical mastitis history. All quarters 
of all enrolled cows received an internal teat sealant. 
Within each category, cows were randomly allocated 
to 1 of 3 groups; in one group antibiotic treatment 
was allocated at cow level (i.e., all 4 quarters received 
antibiotic), whereas in the 2 remaining groups antibi-
otic treatment was allocated at quarter level, based on 
California Mastitis Test (CMT) findings. Two different 
thresholds, score 1 and 2, were used to determine likely 
infection status. Quarter milk samples were collected 
at dry off and postcalving for bacteriological culture 
and somatic cell count (SCC). Cows were monitored for 
clinical mastitis from dry off until 100 d in milk. Cow 
level SCC and milk yield data were collated from farm 
records. Within each category, the 2 quarter level treat-
ment groups were compared with cow level treatment at 
dry off. Leaving quarters untreated with intramammary 
antibiotic in cows in the high cell count group, with a 
CMT <2 or <1, reduced antibiotic use by 55% and 31%, 
respectively, and resulted in no difference in the odds 
of being infected with any pathogen postcalving, but 
was associated with a higher SCC at the first test day. 
Intramammary antibiotic treatment of quarters with a 
CMT ≥1 in cows in the low cell count category at dry 
off was not associated with any reduction in the odds 
of being infected with a major pathogen postcalving 
but was associated with a decrease in the odds of being 
infected with a minor mastitis pathogen postcalving. 
The use of antibiotics in quarters of cows categorized 
as low cell count at dry off, increased the proportion of 
quarters treated with antibiotic from 0% at cow level to 
31% (CMT ≥ 1) and 12% (CMT ≥ 2) at quarter level, 
only resulting in a reduction in SCC of around 20,000 
cells/mL at the first test day, if all quarters with CMT 
score ≥1 were treated with antibiotic. No differences in 
clinical mastitis incidence and milk yield in the first 100 
d in milk were detected between any of the treatment 
groups. These study findings support selective quarter 
level dry off treatment only in cows with cow level SCC 
>200,000 cells/mL at dry off.
Key words: selective dry cow treatment, California 
Mastitis Test, intramammary infection, antibiotic, teat 
sealant
INTRODUCTION
Antibiotic dry cow treatment is widely used for the 
cure and prevention of IMI (Halasa et al., 2009a,b). 
Three strategies have been recommended (Kabera et 
al., 2020; Rowe et al., 2020a): treatment of all cows 
to be dried off with antibiotics (AB) regardless of in-
fection status (blanket cow level treatment, BCLT), 
treatment of all 4 quarters of infected cows (selective 
cow level treatment, SCLT), and treatment of infected 
quarters (selective quarter level treatment, SQLT).
Blanket cow level treatment has been a cornerstone 
of the “5-point plan” (Neave et al., 1969) for mastitis 
control for many decades, and has contributed to a sig-
nificant reduction in IMI (Bradley, 2002). This reduc-
tion has, over time, resulted in AB at drying off (DO) 
being mainly prescribed in healthy, low SCC quarters 
to prevent new infections rather than for treating 
pre-existing infection. Increased public health concern 
about the prophylactic use of AB (European Medicines 
Agency, 2016), and the introduction of teat sealants as 
effective alternatives to prevent new infections, paved 
the way for SCLT.
Selective cow level treatment is well supported in the 
scientific literature (Green et al., 2002; Bradley et al., 
2003; Scherpenzeel et al., 2014; Rowe et al., 2020a,b) 
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and is increasingly implemented in dairy herds. Selec-
tive cow level treatment protocols are designed to use 
AB only in infected cows at DO. In the absence of 
alternative strategies for preventing new infection, such 
as an internal teat sealant, this approach leads to an 
increase in the risk for new IMI (Schukken et al., 1993; 
Berry and Hillerton, 2002a; Scherpenzeel et al., 2014). 
Internal teat sealants have been shown to be an effec-
tive alternative to AB for preventing new IMI in low 
SCC cows (Berry and Hillerton, 2002b; Huxley et al., 
2002; Rabiee and Lean, 2013). However, a teat sealant 
is also recommended in infected cows combined with 
an AB treatment because combination treatment is 
equally (Vanhoudt et al., 2018; Kabera et al., 2020) 
or more effective (Newton et al., 2008; Bradley et al., 
2010; Golder et al., 2016) in the prevention of new IMI, 
than AB alone. Therefore, SCLT programs increasingly 
advocate using a teat seal in all, both infected and un-
infected, cows at DO.
Selective cow level treatment is performed at cow 
level because quarters have been considered interde-
pendent within cows (Berry et al., 2003; Robert et 
al., 2006; Blagitz et al., 2015) and an increased risk of 
infection is perceived in uninfected quarters in infected 
cows. However, quarter interdependence may be less 
marked with environmental than contagious mastitis 
pathogens (Barkema et al., 1997) because the risk of 
new infection from the environment is assumed to be 
the same for all 4 quarters.
Selective quarter level treatment has been recom-
mended some time ago (Osterås and Sandvik, 1996) 
and may indeed potentially be a more refined method 
of reducing the use of AB and result in equal overall 
dry period outcomes, when compared with SCLT (Pa-
tel et al., 2017). However, to date, SQLT is not well 
understood because peer-reviewed data on the outcome 
of dry period treatments allocated at quarter level are 
limited. In an Australian study (Browning et al., 1990), 
new infections were increased following quarter level 
treatment of cows infected at DO, though most infec-
tions were caused by Streptococcus uberis and Staphy-
lococcus aureus. These findings, and those of Brown-
ing et al. (1994), may not be transferable to modern, 
well-managed herds with a low prevalence of contagious 
pathogens, and a mastitis etiology dominated by en-
vironmental pathogens such as Escherichia coli, other 
Enterobacteriaceae, and minor pathogens such as CNS 
and Corynebacterium spp., an etiology frequently seen 
in the United Kingdom. In herds with a low bulk milk 
somatic cell count (BMSCC) consistently <250,000 
cells/mL for at least 12 mo, SQLT was shown to be a 
viable option to decrease antibiotic use by 58% without 
any negative effect on udder health, when compared 
with BCLT (Kabera et al., 2020).
Currently, selective cow level programs in the United 
Kingdom are mainly performed in herds engaged in 
DHI programs with varying SCC thresholds and strat-
egies used for identifying cows with an IMI at DO. 
However, SQLT requires a diagnosis at quarter level 
which is not routinely available. The California Mas-
titis Test (CMT), first described and used in 1957 
(Schalm and Noorlander, 1957), has been accepted as a 
practical, quick, simple, and easy-to-do cow-side test to 
predict SCC at DO from individual quarters (Sanford 
et al., 2006). Sanford et al. (2006) reported the nega-
tive predictive value of CMT was >95% in herds with 
low major pathogen IMI prevalence at DO, typically 
associated with a low BMSCC, so that SQLT might 
be reasonable for such herds if quarters were screened 
with CMT.
The objective of this study was to compare antibi-
otic use and dry period outcomes of SQLT and SCLT, 
in dairy herds in the United Kingdom, using CMT to 
determine infection status at the quarter level at DO. 
Our hypothesis was that selecting antibiotic dry cow 
therapy at the quarter rather than cow level could fur-
ther refine antibiotic use without detriment to udder 
health.
MATERIALS AND METHODS
This study was conducted under Animal Test Certifi-
cate No: ATC-S-084 under The Veterinary Medicines 
Regulations 2013 SI 2013/2033 issues by the Veterinary 
Medicines Directorate, Surrey, United Kingdom.
Herd Selection
Six commercial farms with conventional milking 
systems in the southwest of England were selected to 
participate based on likely compliance with the study 
protocol, a low prevalence of contagious pathogens 
based on historical clinical knowledge of these herds, 
showing classic contagious pathogens such as S. aureus 
representing less than 5% of all major pathogen infec-
tions, and with no infections with Streptococcus agalac-
tiae for at least 10 yr, a history of BMSCC less than 
250,000 cells/mL (milk sold off farm) in the past 12 mo, 
monthly individual cow SCC testing, and retrospective 
records of clinical mastitis (CM) for at least 12 mo. 
Cows were managed according to normal husbandry 
practices on the farm. On each farm, farm-specific data 
such as BMSCC, herd size, management, and housing 
data were collated.
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Cow Selection
Cows were enrolled before their final milking in lacta-
tion and assessed for suitability for enrollment, over 
a 12-mo period, from July 2017 to July 2018, to al-
low seasonal effects to be investigated. Animals were 
eligible for enrollment if, according to study person-
nel, based on an assessment of farm records and a 
clinical inspection they were in good general health, 
had 4 functional quarters, and had been enrolled on 
a monthly SCC scheme for at least the 3 preceding 
months. Animals were not eligible for enrolling if they 
had intercurrent disease based on physical inspection, 
were expected to calve within the minimum dry period 
of 32-d withdrawal time as labeled for CEFA-SAFE 
Dry Cow (MSD Animal Health), or had received paren-
teral or intramammary treatment with an antibacterial 
or antiinflammatory medication during a 30-d period 
immediately before recruitment to the study. Animals 
were withdrawn from the study and censored in any 
analysis based on welfare grounds (i.e., disease, injury, 
or disability), or in case of any abnormality (other than 
mastitis) requiring AB or antiinflammatory treatment 
during the dry period and the first 100 d of the subse-
quent lactation.
Study Protocol
Enrollment. Farms were visited weekly by a mem-
ber of the research team. At enrollment, key cow pa-
rameters were collated from farm records, including, 
but not limited to, breed, parity, milk yield, SCC and 
CM history, treatment history, and estimated calving 
date. Before the final milking and before treatment al-
location and administration, each animal was assessed 
for suitability for inclusion in the study based on inclu-
sion and exclusion criteria. Cows were then randomly 
selected for inclusion in the study based on the need 
to recruit cows in equal numbers, on each farm, on the 
basis of their SCC category (see below). On each day 
of recruitment, all cows eligible to be dried off were 
presented by the farmer. The farmer was blinded to 
the methods of cow recruitment. These cows were then 
sorted, by study personnel, by ascending line number 
and recruited in blocks of 6 animals, 3 to each SCC 
category. Significant numbers of low SCC cows were 
not recruited as they tended to outnumber cows in the 
high SCC category.
Teat end callosity (TEC) scores (Neijenhuis et al., 
2000) and a BCS was performed according to the 
DairyCo Guide, available at https: / / ahdb .org .uk/ 
knowledge -library/ body -condition -scoring -flow -chart.
Duplicate milk samples were collected aseptically for 
bacteriology and a single sample for SCC determina-
tion was collected from each quarter of each recruited 
cow using a method described previously (Bradley and 
Green, 2000). A CMT test was also performed, cow 
side, on each quarter following a method and scoring 
previously described (Leach et al., 2008); any reaction 
was scored on a range from 0 to 3, where 0 represented 
no evidence of thickening or gel formation, 1 a trace 
reaction (slight thickening of the liquid forms but no 
gel formation), 2 a weak positive (thickens immediately 
and gel formation is suggested), and 3 a distinct or 
strong positive (a clear gel is formed).
Treatment Allocation and Administration. The 
overall allocation of cows to treatment groups is sum-
marized in Figure 1. At DO, cows were categorized as 
high or low SCC based on CM and SCC history. Cows 
with any of the last 3 monthly individual SCC ≥200,000 
cells/mL or an occurrence of CM within that period 
were categorized to the high SCC group; all other cows 
(i.e., with low SCC and no CM) were categorized to the 
low SCC group.
Within each of the 2 categories cows were randomly 
allocated, by study personnel, based on a randomized, 
pre-allocated order of treatment group within recruit-
ment blocks. Farm personnel were blinded to product 
administration. These 3 treatment groups comprised 
either SCLT where all quarters received the same treat-
ment or quarter level treatment allocation where AB 
treatment was applied at the quarter level according to 
a CMT score. In the SQLT groups, treatments were al-
located using a CMT score threshold of 1 (SQLT1) or 
2 (SQLT2). Because both the high SCC (H) and low 
SCC (L) category cows contained these 2 quarter level 
groups, we abbreviated them as H-SQLT1, H-SQLT2 
and L-SQLT1, L-SQLT2.
All treatments were administered following strict 
asepsis, according to datasheet recommendations by a 
member of the study team. When cows or quarters were 
eligible to receive AB treatment, an intramammary AB 
(cephapirin benzathine, 300 mg, CEFA-SAFE, MSD 
Animal Health) was administered before applying the 
teat sealant in the same quarter. All quarters of all cows 
in the study received an internal teat sealant (Bismuth 
subnitrate, 2.6 g, and povidone, CEPRALOCK, MSD 
Animal Health).
When treatments were allocated at the cow level 
(SCLT), cows in the high SCC category received AB in 
all 4 quarters before an internal teat sealant, whereas 
all 4 quarters in cows in the low SCC category received 
an internal teat sealant alone. When treatments were 
allocated at the quarter level (SQLT), all quarters still 
received an internal teat sealant, but AB treatment was 
indicated by the CMT score, with the threshold differ-
ing for the SQLT1 and SQLT2 groups, regardless of 
SCC category.
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Two different quarter level CMT score thresholds 
were used to facilitate investigation of the most ap-
propriate threshold for optimizing dry period outcomes 
and AB use. Irrespective of SCC category, quarters in 
cows allocated to the SQLT1 group received AB treat-
ment if a quarter CMT showed at least a trace reaction 
(score ≥1). Quarters of cows assigned to the SQLT2 
group received AB treatment when a quarter CMT 
showed at least a weak positive reaction (score ≥2).
Dry Period Management. Following DO, cows 
were managed according to the normal husbandry 
practices for each of the study farms. Any concurrent 
treatments were recorded, and CM cases sampled 
for bacteriology by farm personnel trained in aseptic 
sample collection.
Postcalving. Experienced, trained study personnel 
took duplicate aseptic milk samples for bacteriology 
and a single sample for SCC from each quarter at the 
first weekly visit after calving. Samples collected more 
than 10 d after calving were excluded from the analy-
sis of efficacy as measured by the cure and acquisition 
of IMI during the dry period. In addition, cows were 
scored for BCS and quarters for TEC. At the second 
weekly visit postcalving, quarters were again sampled 
for SCC determination.
Calving to 100 DIM. All CM cases were sampled 
and recorded by trained farm personnel; samples were 
then frozen on farm until collection at the weekly visit. 
Details of any other disease or concurrent treatments 
were collated as were DHI data relating to monthly 
milk production and individual cow SCC.
Laboratory Methods. All milk samples collected 
were maintained at or below 8°C during transport to 
the laboratory for analysis. Microbiological investiga-
tion and SCC were carried out in accordance with 
the methods recommended by the International Dairy 
Federation (IDF, 1981; Bulletin No. 132), and Interna-
tional standard 13366-1: 1997 (E) and 13366-2: 1997 
(G). In summary, samples were inoculated onto blood, 
MacConkey, and Edwards agar and incubated for 72 
h at 37°C. Both the blood and Edwards agar were in-
oculated with 10 μL of milk. The MacConkey agar was 
inoculated with 100 μL of milk to enhance the chances 
of isolation of Enterobacteriaceae. All organisms were 
identified and enumerated. Organisms were identified 
primarily by using MALDI-TOF MS, but also, where 
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Figure 1. Overview of the study design and overall allocation of cows to treatment groups, from a study in the United Kingdom comparing 
selective dry cow treatment at cow level to selective dry cow treatment at quarter level in dairy cows. Eight hundred seven cows were recruited 
to the study at drying off (DO), of which 766 calved, and 764 were available for analysis. High SCC cows: any of the last 3 monthly individual 
cow SCC ≥200,000 cells/mL, before DO, or any clinical mastitis case occurring in the time period from the day of the third monthly individual 
cow SCC test before DO, to the day of DO. Low SCC cows: all of the last 3 monthly individual cow SCC <200,000 cells/mL, before DO, and 
no clinical mastitis occurred from the day of the third monthly individual cow SCC test before DO to the day of DO. L- = low SCC category 
at DO; H- = high SCC category at DO. SCLT = selective cow level treatment; SQLT1 = selective quarter level treatment CMT (California 
Mastitis Test) positive, showing at least a trace (CMT score ≥1); SQLT2 = selective quarter level treatment CMT positive, at least a weak 
positive (CMT score ≥2); AB = antibiotic; ITS = internal teat sealant.
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necessary, based on typical colony morphology, Gram 
staining, and further biochemical tests. Isolation of 
an organism in pure or mixed growth was considered 
indicative of an IMI. A sample was considered contami-
nated if >3 pathogens were cultured from a sample. If 
this occurred, the duplicate sample was submitted for 
bacteriological analysis (Bradley and Green, 2000).
For the purposes of analysis, Corynebacterium spp., 
CNS (excluding coagulase-negative S. aureus), and 
other closely related species were considered minor 
mastitis pathogens. For a full breakdown of bacterial 
classifications, see Supplemental Table S1 (http: / / dx 
.doi .org/ 10 .17632/ 4hsr7gykzd .1).
Somatic cell count was determined using the Fosso-
matic method (Delta CombiScope–Model FTIR 400, 
Delta Instruments) according to the FIL IDF 148 A: 95 
norm (IDF, 1995).
Assessment of Efficacy. The primary outcomes 
considered were related to bacteriological status at 
calving and the rate of CM mastitis in the first 100 
DIM in the subsequent lactation, when compared be-
tween treatment groups within infection categories.
The overall and species-specific cure rates were esti-
mated and compared between groups. A cure was de-
fined as the absence of a pathogen at calving that had 
been present at DO. The overall and species-specific 
new infection rates were estimated and compared be-
tween groups. A new infection was defined as the pres-
ence of a pathogen at calving that had not been present 
at DO. Therefore, a quarter infected with a pathogen 
at DO was eligible to acquire a new infection with a 
different pathogen.
Successful dry period outcomes were estimated and 
compared between groups. A successful outcome was 
explored in 2 ways: (1) the absence of a major pathogen 
from the postcalving sample, and (2) the absence of 
minor mastitis pathogen from the postcalving sample.
The overall and species-specific incidence rate of CM 
was assessed in the first 100 DIM lactation and com-
pared between products.
In addition, the effect of the different strategies on 
SCC and milk yield in early lactation and on AB use 
was considered.
Data Collation and Statistical Analysis
Power and sample size calculations based on UK 
data suggested that assuming 80% power and 95% 
confidence in a 2-sided test the proposed sample sizes 
would allow detection of a ≥6% (absolute) difference in 
a successful dry period outcome, given a baseline level 
of 70% of quarters being pathogen free postcalving in 
the SCLT group. Both univariable and multivariable 
analysis were conducted.
Data were collated and initially analyzed using Excel 
and Access (Microsoft Corp.) and Minitab (Minitab 
Inc.). Descriptive and graphical analyses were car-
ried out to explore the data. Univariable analysis of 
treatment efficacy was performed using the chi-square 
test to investigate differences in proportions between 
groups. A layered Bonferroni correction was used to 
allow for multiple comparisons where appropriate (Dar-
lington, 1990). Analysis was undertaken assessing high 
SCC and low SCC cows both separately and together.
Multilevel logistic regression models were specified 
with the response variables: (1) absence of a major 
pathogen postcalving, (2) absence of a minor pathogen 
postcalving, (3) cow level SCC at the first DHI test in 
lactation, or (4) CM on one or more occasions, within 
the first 100 DIM. Random effects were included for 
cow (level 2) and farm (level 3) to account for cor-
relations within the data (i.e., quarters within cows 
and cows within farms). Potential confounding factors 
such as milk yield and infection status at DO, quarter 
location, TEC score, BCS, dry period length, season 
of calving, and parity were tested and included in final 
models if they influenced the treatment effect (>5% 
change in coefficient). The models took the following 
general form:
 Responseijk ~Bernoulli(probability = μijk) 
 logit(μijk) = α + β1TXijk + β2Xijk + β3Xjk   
+ β4Xkvk + ujk,
where vk ~normal distribution (mean = 0, σv
2),  ujk 
~normal distribution (mean = 0, σu
2),  the subscripts i, 
j, and k denote the ith quarter, the jth cow, and the kth 
farm, respectively; μijk = the fitted probability of the 
response in quarter i of cow j in farm k; α = the regres-
sion intercept; TXijk = covariate treatment; β1 = coef-
ficients for TXijk; Xijk = matrix of quarter level covari-
ates; β2 = coefficients for Xijk; Xjk = matrix of cow 
level covariates; β3 = coefficients for Xjk; Xk = matrix 
of farm level covariates; β4 = coefficients for Xk; vk = 
random effect reflecting residual variation between 
farms; ujk = random effect reflecting residual variation 
between quarters of cows; σv
2  = between farm variance; 
and σu
2  = between cow variance. Model building, pa-
rameter estimation, and assessment of model fit were 
performed in MLwiN version 2.10 (Rasbash et al., 
2009).
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RESULTS
Key characteristics of the 6 study herds are shown in 
Table 1. From these herds, 807 cows were recruited to 
the study at DO of which 766 cows calved and data of 
764 cows were available for analysis, of which 381 cows 
were categorized as high SCC, and 383 categorized as 
low SCC. In the high SCC category, the number of 
cows for each of the 3 treatment groups was H-SCLT 
(n = 126), H-SQLT1 (n = 122), and H-SQLT2 (n = 
133) and in the low SCC category; L-SCLT (n = 125), 
L-SQLT1 (n = 128), and L-SQLT2 (n = 130) (Figure 
1). A summary of cow and quarter level data is shown 
in Table 2. No significant differences were identified 
between the 3 groups within the high SCC and low 
SCC categories (P > 0.05).
Univariable Analysis
Prevalence of Infection at DO. The prevalence of 
key mastitis pathogens and pathogen groups at DO and 
calving by treatment group in cows categorized as high 
and low SCC at DO are summarized in Tables 3 and 
4, respectively. When comparing within SCC category 
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C F H M R T
Herd size (number of cows in milk) 730 225 249 150 223 580
Number of cows enrolled 250 93 113 46 100 205
12-mo geometric mean BMSCC1 122 171 146 155 237 313
Clinical mastitis incidence in 12 mo before study start2 20 34 74 42 77 23
305-d milk yield (L) at study start3 10,115 9,975 8,790 7,633 7,716 10,878
Predominant breed4 HF HF HF HFX HF HF
Dry cow winter housing5 C, Y C, Y Y C, Y C, Y C, Y
Dry cow summer housing5 P C, Y P P P Y
Dry cow bedding Sand Sand Straw Straw Straw Straw
Milking frequency/d 3× 2× 2× 2× 2× 3×
1Calculated bulk milk SCC (× 1,000/mL) based on individual cow recording.
2Cases/100 cows per year.
3Cows and heifers.
4HF = Holstein Friesian; HFX = Holstein Friesian Cross.
5C = cubicles; Y = yards; P = pasture.
Table 2. Summary of mean (and SD) cow and quarter level data of the 3 treatment groups within each SCC category at drying off (DO; high 
and low SCC), in descending use of antibiotics from left to right, from a study in the United Kingdom comparing selective dry cow treatment 





H-SCLT H-SQLT1 H-SQLT2 L-SQLT1 L-SQLT2 L-SCLT
Cow level DO       
 n (cows) 126 122 133 128 130 125
 Parity 2.55 (1.37) 2.60 (1.48) 2.48 (1.39) 2.11 (1.34) 2.18 (1.17) 2.00 (1.23)
 Milk yield (L) 16.4 (8.58) 16.8 (9.32) 17.0 (9.67) 17.7 (7.98) 18.3 (8.18) 18.7 (8.23)
 BCS 2.98 (0.58) 3.00 (0.62) 2.99 (0.57) 2.83 (0.55) 2.87 (0.52) 2.96 (0.60)
 Cow lnSCC 1 mo before DO 5.51 (0.93) 5.57 (1.01) 5.63 (0.80) 4.19 (0.79) 4.12 (0.72) 4.08 (0.69)
 Cow lnSCC 2 mo before DO 5.32 (0.93) 5.28 (1.06) 5.32 (0.80) 3.99 (0.66) 3.94 (0.69) 3.87 (0.65)
 Cow lnSCC 3 mo before DO 5.21 (1.21) 5.13 (1.10) 5.17 (1.14) 3.88 (0.78) 3.66 (0.68) 3.78 (0.71)
 Dry period length (d) 57.8 (24.5) 54.0 (16.6) 57.2 (26.7) 53.5 (15.2) 53.4 (18.3) 54.5 (18.6)
Quarter level DO       
 n (quarters) 504 488 532 512 520 500
 CMT score 1.23 (1.02) 1.30 (1.07) 1.23 (1.08) 0.43 (0.73) 0.45 (0.74) 0.39 (0.69)
 TEC score 1.85 (0.69) 1.85 (0.72) 1.95 (0.76) 1.74 (0.65) 1.76 (0.64) 1.73 (0.66)
 lnSCC 5.65 (1.39) 5.55 (1.45) 5.65 (1.42) 4.41 (1.24) 4.39 (1.25) 4.30 (1.20)
1Differences between treatment groups within SCC category were not significant (P > 0.05).
2L- = low SCC category at DO; H- = high SCC category at DO. SCLT = selective cow level treatment, all quarters of cows receiving an an-
tibiotic tube + teat sealant when high SCC at DO, and a teat sealant only when low SCC at DO. SQLT1 = selective quarter level antibiotic 
treatment when CMT (California Mastitis Test) positive, showing at least a trace (CMT score ≥1). SQLT2 = selective quarter level antibiotic 
treatment when CMT positive, showing at least a weak positive (CMT score ≥2). TEC = teat end callosity.
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(i.e., high or low SCC), no significant differences (P > 
0.05) were observed between treatment groups in the 
high SCC category at DO. However, in the low SCC 
category, when allowances had been made for multiple 
comparisons, quarters in the L-SQLT1 treatment group 
were significantly less likely to yield no growth on cul-
ture than quarters in the L-SCLT (223/512 vs. 258/500; 
P = 0.03) and L-SQLT2 (223/512 vs. 265/520; P = 
0.03) groups.
Apparent Dry Period Cure Rate. The apparent 
dry period cure rates for key mastitis pathogens and 
pathogen groups are summarized in Table 5. In the 
high SCC cow category, no significant differences in 
apparent cure rates for major pathogens were identi-
fied, though the apparent cure rate for minor mastitis 
pathogens was significantly lower in the H-SQLT2 treat-
ment group than in the H-SCLT (268/305 vs. 283/290; 
P < 0.001) or H-SQLT1 (268/305 vs. 272/284; P = 
0.002) treatment groups. This was primarily as a result 
of the difference in the apparent cure rate for minor 
coryneform mastitis pathogens, which was significantly 
lower in the H-SQLT2 treatment group than in H-
SCLT (184/218 vs. 199/205; P < 0.001) or H-SQLT1 
(184/205 vs. 195/205; P < 0.001), as the apparent cure 
rates for minor coccal mastitis pathogens did not differ.
Similarly, in the low SCC cow category, no significant 
differences in apparent cure rates for major pathogens 
were identified, though the apparent cure rate for minor 
coryneform mastitis pathogens was significantly lower 
in the L-SCLT treatment group than in the L-SQLT1 
(74/135 vs. 124/169; P = 0.003) or L-SQLT2 (74/135 
vs. 97/141; P = 0.034) treatment groups.
Apparent Dry Period New Infection Rate. The 
apparent dry period new infection rates for key mastitis 
pathogens and pathogen groups are summarized in Ta-
ble 6. Whereas trends were evident between treatment 
groups in the apparent new infection rate for major 
mastitis pathogens in the low SCC category, no signifi-
cant differences were identified for any of the pathogen 
or pathogen groups tested in either SCC category.
Dry Period Outcomes. When comparing treat-
ment groups at calving, within the high SCC category 
(Table 3) no significant differences were identified, with 
the exception that quarters in cows in the H-SCLT 
group were significantly less likely to be infected with 
a minor coryneform organism than quarters in the H-
SQLT2 group (34/504 vs. 75/532, P < 0.001). In the 
low SCC category (Table 4), quarters in cows in the 
L-SCLT group were significantly less likely to be free 
of any pathogen (228/500 vs. 279/512; P = 0.015) and 
significantly more likely to be infected with a minor 
mastitis pathogen (208/500 vs. 175/520; P = 0.045) 
than quarters in cows in the L-SQLT1 group. Quar-
ters in cows in the L-SQLT2 group were also signifi-
cantly more likely to be infected with a major mastitis 
pathogen than quarters in cows in the L-SQLT1 group 
(70/520 vs. 43/512; P = 0.027).
Clinical Mastitis. The rates of CM in all groups 
were low with between 4.65% (low SCC category L-
SQLT1) and 5.75% (low SCC category L-SCLT) of 
quarters affected in the first 100 DIM. Environmental 
pathogens predominated and only 3 cases of S. aureus 
mastitis occurred in study cows. No significant differ-
ences were detected between treatment groups (P > 
0.5).
Postcalving SCC and Milk Yield. The effect of 
treatment group on quarter SCC was similar in both 
the first and second week after calving, with increas-
ingly liberal use of intramammary AB associated with 
lower quarter SCC after calving. In the high SCC cow 
category quarters in cows in the H-SQLT2 group had 
significantly higher lnSCC than quarters in cows in the 
H-SQLT1 (4.08 vs. 3.80; P = 0.006) and H-SCLT (4.08 
vs. 3.74; P < 0.001) groups in the second week after 
calving. In the low SCC cow category quarters in cows 
in the L-SCLT group had significantly higher lnSCC 
than quarters in cows in the L-SQLT2 (4.14 vs. 3.82; 
P = 0.006) and L-SQLT1 (4.14 vs. 3.76; P < 0.001) 
groups in the second week after calving. The effect 
of treatment on cow level SCC at the first DHI test 
after calving is summarized in Table 7. No significant 
differences were identified between treatment groups 
in the cows defined as high SCC at DO; however, in 
the low SCC category, cows in the L-SCLT group had 
significantly higher lnSCC than cows in the L-SQLT1 
group (4.23 vs. 3.75; P = 0.03). Cumulative milk yields 
of the first 100 DIM were compared between treatment 
strategies within SCC category. Mean milk yields were 
3,968 L (H-SCLT), 3,976 L (H-SQLT1), and 3,779 L (H-
SQLT2) when high SCC at DO, and 3,896 L (L-SCLT), 
4,015 L (L-SQLT1), and 4,005 L (L-SQLT2) when low 
SCC at DO. No significant differences were identified 
between treatment groups with infection categories.
Effect on Use of Antibiotic Dry Cow Treat-
ment. The number of AB tubes used in each treatment 
group within each category was calculated and com-
pared with the number of quarters cured of bacterial 
IMI. The findings of this analyses are summarized in 
Table 8. In the high SCC category, significantly fewer 
AB intramammary tubes were used per cure in the H-
SQLT2 and H-SQLT1 treatment groups than in the 
H-SCLT group (3.87 vs. 10.12; P < 0.001 and 5.06 
vs. 10.12; P < 0.001, respectively), but the number of 
tubes used per cure did not differ between the quarter 
level treatment groups. Similarly, in the low SCC cat-
egory, significantly more AB intramammary tubes were 
used per cure in the L-SQLT1 and L-SQLT2 treatment 
groups than in the L-SCLT group (3.24 vs. 0.00; P 
Swinkels et al.: QUARTER LEVEL SELECTIVE DRY COW TREATMENT
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< 0.001 and 2.03 vs. 0.00; P < 0.001, respectively), 
although the number of tubes used per cure also dif-
fered between the L-SQLT1 and L-SQLT2 quarter 
level treatment groups (3.24 vs. 2.03; P = 0.009). The 
relationship between AB tube usage, major pathogen 
apparent cure rate, and major and minor pathogen 
new IMI rates is illustrated in Figure 2. In the high 
SCC cow category, the proportion of quarters treated 
with AB reduces from 100% at cow level (H-SCLT) to 
69% (H-SQLT1) and 45% (H-SQLT2) at quarter level. 
In the low SCC cow category, the proportion of quar-
ters treated with AB increases from 0% at cow level 
(L-SCLT) to 12% (L-SQLT2) and 31% (L-SQLT1) at 
quarter level.
Multivariable Analysis
Dry Period Outcomes. Two dry period outcomes 
were modeled: the likelihood of a quarter being free of 
a major mastitis pathogen and free of a minor mastitis 
pathogen in the high and low SCC categories. In the 
high SCC category, compared with the H-SCLT group, 
the quarter level odds of being infected with a major or 
minor mastitis pathogen was not affected by selection 
of AB. Similarly, in the low SCC category, the odds 
of being infected by a major pathogen did not differ 
between treatment groups. However, differences were 
identified in the likelihood of infection with a minor 
pathogen and are summarized in Table 9; compared 
with the L-SCLT group, quarters in the L-SQLT1 group 
were at significantly decreased odds of being infected 
with a minor pathogen (OR 0.66; 95% CI 0.49 to 0.89), 
whereas the L-SQLT2 group did not differ (OR 0.76; 
95% CI 0.57 to 1.02). Compared with quarters in cows 
on the farm with the lowest BMSCC, farm C, quarters 
in cows on 3 farms (F, H, and M) were at significantly 
increased odds of being infected with a minor pathogen 
at calving; last 24 h milk yield and the presence of a 
coryneform at DO were also found to be influential.
Clinical Mastitis. The likelihood of CM in the 
first 100 DIM was modeled to take into account the 
potential effect of confounding factors. No significant 
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Table 4. Summary of the prevalence of infection at drying off and postcalving of the 3 different treatment groups, in cows in the low SCC cow 
category at drying off, from a study in the United Kingdom, comparing selective dry cow treatment at cow level to selective dry cow treatment 


















n % n % n % n % n % n % n % n %
n 500  512  520  1,532  500  512  520  1,532  
Staphylococcus 
aureus
0 0.00 5 0.96 4 0.78 9 0.59 1 0.20 2 0.38 1 0.20 4 0.26
Streptococcus uberis 1 0.20 1 0.19 0 0.00 2 0.13 8 1.60 12 2.31 6 1.17 26 1.70
Streptococcus 
dysgalactiae
0 0.00 0 0.00 0 0.00 0 0.00 2 0.40 0 0.00 2 0.39 4 0.26
Lactococcus spp. 2 0.40 5 0.96 4 0.78 11 0.72 1 0.20 2 0.38 2 0.39 5 0.33
Enterococcus spp. 1 0.20 0 0.00 0 0.00 1 0.07 5 1.00 2 0.38 3 0.59 10 0.65
Escherichia coli 0 0.00 3 0.58 2 0.39 5 0.33 6 1.20 5 0.96 3 0.59 14 0.91
Fungal spp. 0 0.00 0 0.00 1 0.20 1 0.07 1 0.20 0 0.00 0 0.00 1 0.07
Yeast spp. 4 0.80 4 0.77 1 0.20 9 0.59 3 0.60 8 1.54 1 0.20 12 0.78
All 
Enterobacteriaceae
2 0.40 3 0.58 2 0.39 7 0.46 10 2.00 8 1.54 6 1.17 24 1.57
Gram-positive 
major pathogens
24 4.80 25 4.81 34 6.64 83 5.42 31 6.20 40 7.69 29 5.66 100 6.53
Gram-negative 
major pathogens
8 1.60 10 1.92 20 3.91 38 2.48 16 3.20 26 5.00 16 3.13 58 3.79
Minor coryneform 
spp.
135 27.00 142 27.31 170 33.20 447 29.18 101 20.20 95 18.27 83 16.21 279 18.21
Minor coccal spp. 124 24.80 115 22.12 120 23.44 359 23.43 121 24.20 103 19.81 106 20.70 330 21.54
All major 
pathogens
34 6.80 37 7.12 51 9.96 122 7.96 48 9.60ac 70 13.46a 43 8.40bc 161 10.51
All minor 
pathogens
228 45.60 236 45.38 265 51.76 729 47.58 208 41.60ac 184 35.38bc 175 34.18b 567 37.01
Contaminated 4 0.80 1 0.19 0 0.00 5 0.33 0 0.00 1 0.19 1 0.20 2 0.13
No growth 258 51.60a 265 50.96a 223 43.55b 746 48.69 228 45.60a 253 48.65ab 279 54.49b 760 49.61
a–cDifferent superscripts within a row and within SCC category differ (P ≤ 0.05).
1L- = low SCC category at drying off. L-SCLT = selective cow level treatment, all quarters of cows receiving a teat sealant. L-SQLT1 = selective 
quarter level antibiotic treatment when CMT (California Mastitis Test) positive, showing at least a trace (CMT score ≥1). L-SQLT2 = selective 
quarter level antibiotic treatment when CMT positive, showing at least a weak positive (CMT score ≥2).
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differences were identified between treatment groups 
within either of the infection categories.
Postcalving SCC and Milk Yield. The findings 
of models investigating the effect of treatment on cow 
level SCC at the first DHI test for the high and low 
SCC cow categories are summarized in Tables 10 and 
11, respectively. In the high SCC cow category, com-
pared with cows in the H-SCLT group (received AB in 
all quarters), SCC were significantly higher at the first 
test day in cows the H-SQLT2 group (only receiving 
AB in quarters with a CMT ≥ 2). In the low SCC cow 
category compared with the L-SCLT group (receiving 
no AB), SCC were significantly lower in the L-SQLT1 
group receiving AB in quarters with a CMT ≥ 1).
Models failed to reveal any significant effect of quar-
ter level application of AB dry cow treatment on milk 
yield in early lactation.
DISCUSSION
This is the first large-scale investigation into the se-
lection of dry cow treatment at quarter level, compared 
with selection of dry cow treatment at cow level, using 
CMT to determine infection status at quarter level. 
Historically, dry cow treatment at quarter level has not 
been favored due to lack of independence of quarters 
within cows (Berry et al., 2003). This means the risk of 
missing a major pathogen infection in another quarter 
of a high cell count cow is considered too high. For 
this reason, this study focused on herds with a low 
prevalence of infection at DO, with classic contagious 
pathogens such as S. aureus representing less than 5% 
of all major pathogen infections, and with less than 2% 
of quarters infected with this pathogen at DO, and with 
no infection of Streptococcus agalactiae for the last 10 
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Table 7. Summary of individual cow lnSCC at the first DHI test day in lactation in different treatment groups 
within the different infection categories at drying off (DO), in descending use of antibiotics from top to bottom, 
from a study in the United Kingdom, comparing selective dry cow treatment at cow level to selective dry cow 
treatment at quarter level in dairy cows
Treatment group1 n Mean SEM SD Minimum Maximum
High SCC cow category at DO     
 H-SCLT 126 3.928 0.129 1.447 1.386 7.902
 H-SQLT1 113 3.91 0.137 1.462 1.386 7.757
 H-SQLT2 127 4.133 0.139 1.563 1.609 8.793
Low SCC cow category at DO      
 L-SQLT1 124 3.751bc 0.119 1.33 0.693 8.818
 L-SQLT2 127 3.995ac 0.133 1.499 1.099 8.46
 L-SCLT 122 4.232a 0.143 1.581 1.386 8.84
a–cDifferent superscripts within SCC category differ (P ≤ 0.05).
1L- = low SCC category at DO; H- = high SCC category at drying off. SCLT = selective cow level treatment, 
all quarters of cows receiving an antibiotic tube + teat sealant when high SCC, and a teat sealant only when 
low SCC. SQLT1 = selective quarter level antibiotic treatment when CMT (California Mastitis Test) positive, 
showing at least a trace (CMT score ≥1); SQLT2 = selective quarter level antibiotic treatment when CMT 
positive, showing at least a weak positive (CMT score ≥2).
Table 8. Summary of apparent cure rates and antibiotic tube usage in different treatment groups within infection categories in descending use 
of antibiotics from top to bottom, from a study in the United Kingdom, comparing selective dry cow treatment at cow level to selective dry cow 














High SCC cow 
 category at DO
 H-SCLT 496 53 49 4 92.5 496 10.12a
 H-SQLT1 484 68 66 2 97.1 334 5.06b
 H-SQLT2 528 64 62 2 96.9 240 3.87b
Low SCC cow 
 category at DO
 L-SQLT1 511 49 49 0 100.0 159 3.24a
 L-SQLT2 518 33 32 1 97.0 65 2.03b
 L-SCLT 496 30 29 1 96.7 0 —c
a–cDifferent superscripts within a column and within SCC category differ (P ≤ 0.05).
1L- = low SCC category at drying off (DO); H- = high SCC category at DO; SCLT = selective cow level treatment, all quarters of cows receiv-
ing an antibiotic tube + teat sealant when high SCC at DO, and a teat sealant only when low SCC at DO. SQLT1 = selective quarter level 
antibiotic treatment when CMT (California Mastitis Test) positive, showing at least a trace (CMT score ≥1). SQLT2 = selective quarter level 
antibiotic treatment when CMT positive, showing at least a weak positive (CMT score ≥2). 
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yr. The etiology in these herds is clearly environmental 
and minor pathogens were the predominant organisms 
identified at DO. In such herds, the risk of interdepen-
dence of quarters is lower (Barkema et al., 1997) and 
thus, the probability of missing a major pathogen in 
another quarter in infected cows is lower too. It was in 
this environment that efficacy of selective dry cow AB 
treatment at quarter level, in high and low SCC cows 
at DO was compared with SCLT.
While not perfect, our categorization of cows as high 
SCC or low SCC was successful in defining 2 separate 
groups with significantly different prevalence of infec-
tion at DO with significantly more quarters being free 
of any mastitis pathogen in the low SCC group (48.7%) 
compared with the high SCC group (35.6%), which was 
also reflected in the proportion of quarters free of both 
major and minor mastitis pathogens. This categoriza-
tion appeared useful as it defined 2 populations within 
which the use (or not) of AB had different effects. For 
example, leaving all quarters with a CMT score of <2 
in the high SCC group untreated with intramammary 
antibiotic, resulted in a significant increase in SCC at 
the first DHI test in the subsequent lactation, whereas 
intramammary antibiotic treatment in the equivalent 
quarters in the low SCC group had no significant effect 
on SCC at the first DHI test in the subsequent lacta-
tion.
As with all field studies, there are limitations to this 
research. One limitation is the fact that it was conduct-
ed in a small number of a herds in single geographical 
location (South West England) with a low prevalence 
of contagious mastitis pathogens, though we do not see 
this as limiting how these findings could be general-
ized to similar herds elsewhere. The study was blinded, 
and cow randomization was successful, and while farm 
personnel were blinded to product administration, they 
could not be fully blinded as product characteristics 
could have been evident at calving, though it seems 
unlikely this would have caused any bias. There was 
no difference in the proportion of cows lost to follow 
up in any of the treatment groups meaning that bias 
is unlikely to have been introduced. While this study 
relied on farmer identification of CM as one of the 
outcomes, this would not have introduced any bias, as 
farm personnel were blinded to treatment administra-
tion and any shortcomings in their ability would have 
been reflected across all treatment groups equally.
The data suggest the effect of selecting AB treatment 
at the quarter level is different in the 2 somatic cell 
count categories. In the low SCC cows at DO, adding 
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Figure 2. Illustration of the proportion of quarters receiving antibiotic intramammary treatment at drying off and the associated major 
pathogen cure rate and the major and minor pathogen new infection rate, in each of the treatment groups within SCC category at drying off, 
in descending use of antibiotic from left to right, from a study in the United Kingdom comparing selective dry cow treatment at cow level to 
selective dry cow treatment at quarter level in dairy cows. L- = low SCC category at drying off; H- = high SCC category at drying off; SCLT 
= selective cow level treatment, all quarters of cows receiving an antibiotic tube + teat sealant when high SCC at drying off, and a teat sealant 
only when low SCC at drying off; SQLT1 = selective quarter level antibiotic treatment when CMT (California Mastitis Test) positive, showing 
at least a trace (CMT score ≥1); SQLT2 = selective quarter level antibiotic treatment when CMT positive, showing at least a weak positive 
(CMT score ≥2).
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an AB treatment to a teat sealant in CMT positive 
quarters, lowered both quarter SCC postcalving and 
the probability of being infected with a minor patho-
gen at calving, but had no effect on major pathogen 
prevalence at calving. Significantly lower SCC and 
lower prevalence of minor pathogens was the only 
effect of quarter level treatment compared with cow 
level in this category. However, in an absolute sense, 
these improvements in udder health were small; quarter 
SCC postcalving reduced from 63,000 cells/mL (ln = 
4.14) when DO treatment was at cow level (L-SCLT) 
to 43,000 (ln = 3.76) and 46,000 (ln = 3.82) cells/mL 
when DO treatment was at quarter level, for the L-
SQLT1 and L-SQLT2 group, respectively, while minor 
pathogen prevalence at calving reduced from 41.60% to 
34.18% in the L-SQLT1 group. Also, in this category 
of low SCC cows at DO, there were no effects on CM 
incidence nor on cumulative milk yield in the first 100 
DIM. These limited improvements in udder health 
when dried off at quarter level, probably do not justify 
an increase of AB use from 0% of quarters treated with 
AB in the L-SCLT group to 12.3% (L-SQLT2) and to 
31.1% (L-SQLT1).
In the high SCC cows at DO, leaving CMT negative 
(score 0) quarters untreated with dry cow antibiotic, 
was not associated with any significant increase in 
quarter SCC postcalving. However, leaving quarters 
untreated with dry cow antibiotic, in which there was 
no or only a trace reaction (score 0 and 1) to the CMT, 
was associated with a significant increase in quarter 
SCC postcalving from 42,000 (ln = 3.74) cells/mL to 
60,000 (ln = 4.09) cells/mL. Selective DO off at the 
quarter level had no effect on minor or major pathogen 
prevalence at calving in the multivariable model and 
had no effect on CM incidence and cumulative milk 
yield in the first 100 DIM. The limited rise in SCC, as 
Swinkels et al.: QUARTER LEVEL SELECTIVE DRY COW TREATMENT
Table 9. Summary of the final random effects logistical regression model relating to the likelihood of being infected with a minor mastitis 
pathogen at calving in cows categorized as low SCC at drying off (DO), from a study in the United Kingdom, comparing selective dry cow 
treatment at cow level to selective dry cow treatment at quarter level in dairy cows
Covariate1 Coefficient SE Odds ratio
95% CI
Lower Upper
Intercept −1.494     
Treatment group      
 Antibiotic treatment based on CMT ≥2 (L-SQLT2) −0.276 0.147 0.76 0.57 1.02
 Antibiotic treatment based on CMT ≥1 (L-SQLT1) −0.418 0.150 0.66 0.49 0.89
Reference: cow level treatment (L-SCLT; sealant only)      
 Parity 2 0.109 0.153 1.12 0.82 1.51
 Parity 3 −0.025 0.209 0.98 0.64 1.48
 Parity ≥4 0.278 0.199 1.32 0.89 1.97
Reference: parity = 1      
 Farm F 0.562 0.239 1.75 1.09 2.83
 Farm H 0.997 0.283 2.71 1.54 4.77
 Farm M 0.899 0.322 2.46 1.29 4.68
 Farm R 0.297 0.250 1.35 0.82 2.22
 Farm T −0.014 0.197 0.99 0.66 1.46
Reference: farm C      
 Teat score S 0.255 0.146 1.29 0.96 1.73
 Teat score R −0.059 0.211 0.94 0.62 1.44
 Teat score VR −0.619 1.177 0.54 0.05 5.67
Reference: teat score = N      
 Left-hind −0.023 0.159 0.98 0.71 1.34
 Right-fore 0.017 0.157 1.02 0.74 1.39
 Right-hind −0.054 0.160 0.95 0.69 1.30
Reference: quarter location left-fore      
 Minor coryneform organism present at DO 0.99 0.145 2.69 2.01 3.60
Reference: minor coryneform organism not present at DO      
 Minor coccal organism present at DO 0.029 0.137 1.03 0.78 1.35
Reference: minor coccal organism not present at DO      
 Summer calving −0.016 0.175 0.98 0.69 1.40
 Autumn calving −0.270 0.182 0.76 0.53 1.10
 Winter calving −0.292 0.181 0.75 0.52 1.07
Reference: spring calving      
 BCS at DO 0.073 0.122 1.08 0.84 1.37
 Dry period length −0.003 0.004 1.00 0.99 1.01
 Last milk yield (24 h before DO) 0.024 0.012 1.02 1.00 1.05
1L- = low SCC category at DO; L-SQLT1 = selective quarter level antibiotic treatment when CMT (California Mastitis Test) positive, showing 
at least a trace (CMT score ≥1). L-SQLT2 = selective quarter level antibiotic treatment when CMT positive, showing at least a weak positive 
(CMT score ≥2).
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a result of withdrawing treatment from CMT-negative 
quarters compared with cow level treatment, is a 
relatively small detriment to udder health and when 
weighed against the substantial reduction in AB use 
of 31% (H-SQLT1), some degree of quarter level DO 
seems justifiable compared with cow level in the high 
SCC cow category (H-SCLT) at DO.
Based on these data we suggest quarter level DO 
can only be justified for leaving CMT-negative quarters 
untreated with dry cow antibiotic in high SCC infected 
cows at DO. This is in line with the findings of others 
(Patel et al., 2017; Kabera et al., 2020) who found that 
by DO at quarter level, AB use can be reduced with-
out detriment to udder health. However, these authors 
compared SQLT with BCLT and used bacteriological 
culture to determine infection status at DO at the quar-
ter level, whereas in this study SQLT was compared 
with SDCT, and CMT was used.
Farmers have indicated concern about the extra la-
bor and the financial consequences of switching from 
blanket to selective dry cow treatment at the cow level 
(Scherpenzeel et al., 2016). Therefore, both a high con-
venience and a low price of determining infection status 
at dry off may remove barriers to adoption of such pro-
grams (Friedman et al., 2007). Recently, the use of on-
farm culture systems such as 3M Petrifilm (Cameron et 
al., 2014; Kabera et al., 2020) and the Minnesota Easy 
4Cast (Patel et al., 2017; Rowe et al., 2020a,b) were 
used to determine infection status at dry off, assuming 
culture would have a higher sensitivity and specificity, 
compared with indirect tests such as SCC. However, 
Rowe at al. (2020a,b) showed an algorithm-guided cow-
level test method based on SCC and CM history was as 
good as an on-farm culture system in achieving favor-
able dry period outcomes and antibiotic use reduction 
when compared with on-farm culture guided SDCT. 
If as good as on-farm culture, an algorithm guided 
diagnosis to detect infection status at DO, based on 
SCC and CM history, such as in this study, is prefer-
able because of the higher convenience and lower price 
compared with on-farm culture. Because the algorithms 
used to determine infection at DO vary widely between 
studies, some being more (Rowe et al., 2020a,b) or less 
strict (Scherpenzeel et al., 2014) when compared with 
this study, more research is needed on this topic to 
optimize such algorithms.
High convenience and low price of diagnostic tests 
at DO become even more relevant in selective dry cow 
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Table 10. Summary of the final random effects logistical regression model relating to the effect of treatment group on the individual cow SCC 
at the first DHI test in lactation in cows categorized as high SCC at drying off (DO), from a study in the United Kingdom, comparing selective 




Intercept 0.057    
Treatment group     
 Sealant-only treatment based on CMT <2 (H-SQLT2) 0.307 0.092 0.123 0.491
 Sealant-only treatment based on CMT <1 (H-SQLT1) 0.135 0.094 −0.053 0.323
Reference: cow level treatment (H-SCLT; antibiotic + sealant)     
 Parity 2 −0.018 0.107 −0.232 0.196
 Parity 3 −0.181 0.123 −0.427 0.065
 Parity ≥4 0.595 0.119 0.357 0.833
Reference: parity = 1     
 Farm F 0.998 0.158 0.682 1.314
 Farm H 1.25 0.157 0.936 1.564
 Farm M 0.226 0.168 −0.110 0.562
 Farm R 0.989 0.147 0.695 1.283
 Farm T −0.001 0.118 −0.237 0.235
Reference: farm C     
 Summer calving −0.089 0.118 −0.325 0.147
 Autumn calving −0.466 0.116 −0.698 −0.234
 Winter calving −0.593 0.120 −0.833 −0.353
Reference: spring calving     
 BCS at DO 0.364 0.095 0.174 0.554
 BCS at calving −0.174 0.099 −0.372 0.024
 Dry period length 0.009 0.002 0.005 0.013
 Last milk yield (24 h before DO) 0.016 0.006 0.004 0.028
 lnSCC in first month before DO 0.023 0.049 −0.075 0.121
 lnSCC in second month before DO 0.213 0.045 0.123 0.303
 lnSCC in third month before DO 0.172 0.035 0.102 0.242
1H- = high SCC category at DO. SQLT2 = selective quarter level treatment antibiotic when CMT (California Mastitis Test) positive, showing 
at least a weak positive (CMT score ≥2). SQLT1 = selective quarter level antibiotic treatment when CMT positive, showing at least a trace 
(CMT score ≥1).
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treatment programs at the quarter level, when the num-
ber of samples to define infection status is quadrupled 
compared with the cow level. Although on-farm culture 
was recently also suggested as a way to determine infec-
tion status at the quarter level (Kabera et al., 2020), 
for the reasons indicated above, we used the CMT be-
cause it is a fast, easy, and cheap test (Rindsig et al., 
1979; Dingwell et al., 2003). In addition to the test, 
quarter level treatment of only those cows categorized 
as high SCC at DO, as this study is suggesting, does 
not require much extra financial nor time investment 
because, in low SCC herds, the proportion of infected 
and AB-treated cows at DO is usually less than 25% 
(Vilar et al., 2018).
If barriers for DO at quarter level are overcome, our 
study shows AB use at DO can be substantially reduced 
by a range of 11 to 57% in study herds. This reduction 
would be on top of antibiotic reductions of 21% (Cam-
eron et al., 2014) and 55% (Rowe et al., 2020a) as shown 
by others to already be achieved by switching from 
blanket to selective dry cow treatment at the cow level. 
Such approaches are in line with recommendations of 
prudent AB use coming from a growing concern regard-
ing the potential for AB use in food animals to promote 
the future emergence of antimicrobial resistance in bac-
teria (O’Neill, 2014). It should be noted this potential 
AB reduction through DO off at quarter level can only 
be achieved on well-managed low BMSCC farms with 
the associated underlying mastitis pathogen etiology as 
identified in this study, using a teat seal in all quarters, 
with farmers having the right attitude (Scherpenzeel et 
al., 2016) and under the careful guidance and monitor-
ing of a capable veterinarian. This all suggests that if 
cows and udder health are managed well, few AB are 
needed at DO.
Inadequate sensitivity and specificity of tests to de-
tect infection status at DO has been proposed as a rea-
son for the detrimental effect on udder health of some 
reported selective dry cow treatment programs (Patel 
et al., 2017). Indeed, CMT has been shown to not be 
sensitive enough for use as a screening test for IMI 
in high SCC herds (Middleton et al., 2004). Also, the 
positive predictive value of CMT in herds with a bulk 
tank between 300,000 and 400,000 cells/mL was low; 
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Table 11. Summary of the final random effects logistical regression model relating to the effect of treatment 
group on the individual cow SCC at the first DHI test in lactation in cows categorized as low SCC at drying 
off (DO), from a study in the United Kingdom, comparing selective dry cow treatment at cow level to selective 




Intercept 0.856    
Treatment group     
 AB treatment based on CMT ≥2 (L-SQLT2) −0.166 0.085 −0.336 0.004
 AB treatment based on CMT ≥1 (L-SQLT1) −0.467 0.086 −0.639 −0.295
Reference: cow level treatment (L-SCLT; sealant only)     
 Parity 2 0.073 0.088 −0.103 0.249
 Parity 3 0.257 0.122 0.013 0.501
 Parity ≥ 4 0.537 0.119 0.299 0.775
Reference: parity = 1     
 Farm F 0.955 0.140 0.675 1.235
 Farm H 1.943 0.154 1.635 2.251
 Farm M 1.729 0.171 1.387 2.071
 Farm R 1.103 0.139 0.825 1.381
 Farm T 1.013 0.102 0.809 1.217
Reference: farm C     
 Summer calving 0.090 0.103 −0.116 0.296
 Autumn calving −0.136 0.104 −0.344 0.072
 Winter calving −0.430 0.102 −0.634 −0.226
Reference: spring calving     
 BCS at DO 0.328 0.093 0.142 0.514
 BCS at calving −0.190 0.103 −0.396 0.016
 Dry period length 0.002 0.002 −0.002 0.006
 Last milk yield (24 h before DO) 0.023 0.007 0.009 0.037
 lnSCC in first month before DO 0.125 0.063 −0.001 0.251
 lnSCC in second month before DO 0.006 0.069 −0.132 0.144
 lnSCC in third month before DO 0.230 0.062 0.106 0.354
1L- = low SCC category at DO. SQLT2 = selective quarter level treatment antibiotic when CMT (California 
Mastitis Test) positive, showing at least a weak positive (CMT score ≥2). SQLT1 = selective quarter level 
antibiotic treatment when CMT positive, showing at least a trace (CMT score ≥1).
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around 40% in late lactation samples (Godden et al., 
2017). But in herds, such as in this study, where major 
pathogen prevalence is low (<10%), CMT seems an 
acceptable test at DO because the negative predictive 
value, or the proportion of test-negative animals that 
are truly negative, can be >95% (Sanford et al., 2006). 
This means that in low SCC herds, a very small propor-
tion (1 − negative predictive value = less than 5%) of 
truly infected cows (with major pathogens) would not 
receive AB dry cow treatment, which is ultimately the 
goal of a selective dry cow treatment program. Our 
study showed around 70% of quarters in the high SCC 
cow category had a positive CMT, and around 70% 
of quarters in the low SCC category had a negative 
CMT, suggesting that CMT at the quarter level is not 
a perfect, but an acceptable test to determine infec-
tion status for quarters at DO. This is in line with 
the findings of Godden et al. (2017) that quarter level 
CMT tests demonstrated fair to good sensitivity and 
specificity in late lactation quarters, depending on the 
cut-off threshold score selected. However, interpreting 
a CMT test outcome can be subjective. Although we 
tried to reduce subjectivity by using a trained experi-
enced technician or veterinarian for all cows, untrained 
farmers themselves would be performing the test in the 
field. The sensitivity of IMI detection by CMT per-
formed by farmers has been shown to be low (Wallace 
et al., 2004). Thus, when SQLT is installed using CMT 
to detect infection status at quarter level, it will be 
important to train motivated farmers to correctly and 
uniformly interpret CMT results.
In this study a teat seal was used in all quarters in 
all cows. This was done because the evidence of teat 
seal efficacy for the prevention of new infections dur-
ing the dry period is abundant (Berry and Hillerton, 
2002a; Huxley et al., 2002; Krömker et al., 2014), and 
as a result, has become common practice in most herds 
in the United Kingdom. However, DO with teat seal 
is currently not a standard practice everywhere and 
if teat seal is left out of a selective dry cow treatment 
approach, low SCC cows at DO may go unprotected 
for new infections, which, in addition to lack of proper 
management practices at the herd level (Green et al., 
2007), may have been a cause of an increased risk for 
new IMI as reported in earlier studies (Berry and Hil-
lerton, 2002b; Rabiee and Lean, 2013; Scherpenzeel et 
al., 2014). Also, the use of teat seal in all quarters was 
not considered in studies looking at quarter interde-
pendence; it may have increased the independence of 
quarters during the dry period in this study, suggesting 
that the application of teat seal in all cows has greatly 
contributed to the favorable outcome of selective quar-
ter level compared with selective cow level dry cow 
treatment.
Antibiotic treatment at DO seemed to be very ef-
fective because high cure rates were achieved, being 
consistently above 85%. However, we did not compare 
AB efficacy to a negative control (no treatment), but 
compared combined use with a teat sealant to a teat 
sealant alone which tends to overestimate AB cure 
rates, likely explaining the high major pathogen ap-
parent cure rates being consistently above 85%, as was 
also reported in earlier studies (Bradley et al., 2010; 
Kiesner et al., 2016; Vasquez et al., 2018). In the low 
SCC cow category at DO, where cow level treatment 
did not receive any AB at all, apparent self-cure rates 
were approaching 100%, meaning new infection ac-
counts for the majority of infections present at calving. 
These high self-cure rates in low SCC cows at DO sup-
ports the argument that there is no added value for 
superimposing AB treatment on a teat sealant in this 
category of cows.
In this paper we chose to group the non-aureus 
Staphylococcus (NAS) spp. together and treated them 
as a single group. While there is an increasing body of 
evidence to suggest that all NAS are not equal (Valck-
enier et al., 2020; Wuytack et al., 2020), we took this 
approach to facilitate comparison with earlier research 
in the area. A more detailed analysis of the outcomes 
and potential roles of the individual NAS spp. would be 
a fruitful area of future research.
While this research has identified a potential route to 
further reducing AB use, it has also revealed areas in 
need of further research. There are clear differences in 
outcome between herds and cows, suggesting that fur-
ther investigation of cow and herd level factors affecting 
dry period outcome could provide useful insights into 
more appropriate management. Furthermore, because 
any reduction in the proportion of quarters treated 
with antibiotic is welcome, a better understanding of 
how this might affect antimicrobial resistance when 
there is no effect on the proportion of cows treated 
within a herd warrants further investigation.
CONCLUSIONS
Our findings suggest that on well-managed low SCC 
farms, with a low prevalence of major pathogens and 
a predominant environmental mastitis etiology, selec-
tive DO at quarter level using CMT could be a useful 
approach to further support reduction in antimicrobial 
use. This approach can be recommended in high SCC 
cows at DO as a substantial reduction in AB use can 
be achieved with only minor consequences for udder 
health. However, in such herds, the superimposition 
of AB to a teat sealant on high SCC quarters in low 
SCC cows is not necessary and is unlikely to result in 
significant gains in udder health.
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